TNMD anticorps (Middle Region)
Aperçu rapide pour TNMD anticorps (Middle Region) (ABIN955144)
Antigène
Voir toutes TNMD AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 220-249, Middle Region
-
Specificité
- This antibody etects Tenomodulin (TNMD) (Center).
-
Réactivité croisée (Details)
- Species reactivity (tested):Human, mouse
-
Purification
- Protein A column followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 220-249 amino acids from the Central region of human TNMD
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
-
-
- TNMD (Tenomodulin (TNMD))
-
Sujet
- This gene encodes a protein that is related to chondromodulin-I, which is a cartilage-specific glycoprotein that functions to stimulate chondrocyte growth and to inhibit tube formation of endothelial cells. This protein is also an angiogenesis inhibitor. Genetic variation in this gene is associated with a risk for type 2 diabetes, central obesity and serum levels of systemic immune mediators in a body size-dependent manner. This gene is also a candidate gene for age-related macular degeneration, though a direct link has yet to be demonstrated.Synonyms: CHM1L, Chondromodulin-1-like protein, Chondromodulin-I-like protein, Myodulin, Tendin
-
ID gène
- 64102
-
NCBI Accession
- NP_071427
Antigène
-